Viking Therapeutics has launched Part 2 of a study exploring oral and subcutaneous dosing regimens of VK2735, a dual GLP-1/GIP receptor agonist, to maintain weight loss in adults with obesity. This randomized, placebo-controlled trial follows positive results from Part 1, which tested subcutaneous doses. The study aims to find flexible maintenance options to improve long-term adherence and weight management, with results expected in 2027. Viking is also conducting two Phase 3 trials assessing weekly subcutaneous VK2735 for obesity treatment.
Viking Therapeutics' new clinical trial on VK2735 oral maintenance dosing is noted here with Pluang's Health sector market data as of Oct 06, 2026 17:51 WIB. Of 100 priced Health-sector US stocks tradable on Pluang, 67 rose and 25 fell today. Notable movers include TXG at USD 100.73 with a 1-day change of +3.06% and a typical hold time of 93 days, and TWST at USD 209.30 with a 1-day change of +2.10% but with 92% sell order activity. The most notable figure is TXG's 73% buy order activity.
Smallest AI, a San Francisco-based AI research lab, has named Siddharth Sharma as President of Banking, Financial Services, and Insurance (BFSI) in India. Sharma will lead revenue and partnerships, focusing on voice AI solutions tailored for Indian b...
Oil prices fell on Tuesday following diplomatic talks in Tehran involving Saudi Arabia, Turkey, Pakistan, and Iran aimed at reducing tensions in the Middle East. These discussions have raised hopes for de-escalation in the ongoing U.S.-Iran conflict,...
A Grayscale Research report reveals Bitcoin's one-year realized volatility has decreased to 43%, lower than its 10-year average of 64% and below that of many well-known S&P 500 companies like Oracle, Coinbase, Honeywell, and SanDisk. This marks a sig...
Meta Platforms announced the pricing of two major public offerings: $25 billion in Class A common stock and $12.5 billion in Series A mandatory convertible preferred stock. The common stock offering was increased from $22.5 billion to $25 billion, wi...
On October 26, US spot Bitcoin ETFs attracted $110.3 million in net inflows, led by BlackRock's IBIT, marking a rebound after prior redemptions. In contrast, spot Ethereum ETFs experienced $88.6 million in net outflows, with BlackRock's ETHA leading ...
